This is a solid generic manufacturer with a low share count and valuation. There are huge approvals coming and estimates are moving up on currently approved products.Check out growth of earnings and rev's for PRX and I think you will agree.A share buyout at $50 will add immediatetly to PRGO's earnings and explode their generic position in the U.SThey also have an up and coming prorietary division on the cusp of gaining $300 million and more in near term approvals. Two are just a formality and will happen by mid AprilWith a PE of 11 and growing estimates before approvals this is a no brainer. Very little analyst coverage as well
try tjis facts...e p/E 29 and forward p/e 20...looks like expensive stockhttp://finance.yahoo.com/q/ks?s=PRGO
step by step.....up...up....this will be my best investment this year.sure!!!!